Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

@article{Zhang2017EndothelialMD,
  title={Endothelial microparticles delivering microRNA-155 into T lymphocytes are involved in the initiation of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation},
  author={Ran Zhang and Xiaoxiao Wang and Mei Hong and Ting Luo and Miaomiao Zhao and Haorui Shen and Jun Fang and X. Li and Sibin Zang and Ping Chen and Dimin Nie and Peng Zheng and Qiuling Wu and Ling-Hui Xia},
  journal={Oncotarget},
  year={2017},
  volume={8},
  pages={23360 - 23375}
}
Endothelial microparticles (EMPs) upregulation has been observed in acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). However, the role of EMPs remains unclear. We found that EMPs derived from TNF-α-stimulated human umbilical vein endothelial cells (EA.hy926) concentrated more microRNA-155 (miR-155) compared with maternal cells. The miR-155 levels in MPs from peripheral blood of aGVHD patients and mice were remarkably elevated and… 

Figures and Tables from this paper

Extracellular Vesicles as Biomarkers of Acute Graft-vs.-Host Disease After Haploidentical Stem Cell Transplantation and Post-Transplant Cyclophosphamide

TLDR
It is shown that the combination of CD146, sTNFR1, and miR100 or miR194 strongly correlated with the onset of aGvHD (AUROC >0.975) and a potential correlation between EV expression profile and cargo with plasma biomarkers that had been associated with aGVHD previously was investigated.

[Gly14]-Humanin Ameliorates High Glucose-Induced Apoptosis by Inhibiting the Expression of MicroRNA-155 in Endothelial Microparticles

TLDR
This study provides a new direction for biological products related to humanin to treat vascular complications associated with all forms of diabetes mellitus by inhibiting the transfer of EMPs miR-155 from HG-induced HUVECs to normal cells.

Extracellular Vesicles After Allogeneic Hematopoietic Cell Transplantation: Emerging Role in Post-Transplant Complications

TLDR
This review will mainly focus on the immune-modulating properties of EVs, in particular those derived from mesenchymal stromal cells, as potential therapeutic strategy to improve allo-HCT outcome.

A New Era in Endothelial Injury Syndromes: Toxicity of CAR-T Cells and the Role of Immunity

TLDR
This review aims to provide state-of-the-art knowledge on cellular therapies in clinical practice (indications and toxicities), endothelial injury syndromes and immunity, as well as potential therapeutic targets.

Biomarkers for Early Complications of Endothelial Origin After Allogeneic Hematopoietic Stem Cell Transplantation: Do They Have a Potential Clinical Role?

TLDR
This review will define GVHD, TA-TMA and SOS, summarize the current data available in HCT biomarker research and identify promising biomarkers for detection and diagnosis of early HCT complications.

Non-Coding RNA Mediated Regulation of Allogeneic T Cell Responses After Hematopoietic Transplantation

TLDR
The role of various miRNAs that regulate T cell responses, either positively or negatively, to allo-stimulation are reviewed and their potential relevance as biomarkers and as therapeutic targets for improving outcomes after allogeneic BMT are highlighted.

Noncoding RNAs in diagnosis and prognosis of graft‐versus‐host disease (GVHD)

TLDR
An outlook on miRNAs and long noncoding RNAs (lncRNAs) potential role in GVHD is provided with the hope of providing a future research direction for expanding their application as the sensitive and noninvasive diagnostic or prognostic biomarkers and also the promising therapeutic targets for improving outcomes after allogeneic HSCT.

Effects of Cell-Derived Microparticles on Immune Cells and Potential Implications in Clinical Medicine.

TLDR
The effects of MPs on various immune cells are described and plausible potential applications of the immune-modulating properties of MPs in clinical medicine are provided.

Neutrophil microvesicles drive atherosclerosis by delivering miR-155 to atheroprone endothelium

TLDR
Delivery of microvesicles carrying miR-155 to disease-prone regions of arteries provides a novel mechanism by which neutrophils contribute to vascular inflammation and atherogenesis.

References

SHOWING 1-10 OF 51 REFERENCES

Endothelial Cell–Derived Microparticles in Allogeneic Hematopoietic Stem Cell Recipients

TLDR
Evaluation of EMP during acute graft versus host disease (aGVHD) might express severe endothelial cell injury within this complication after hematopoietic stem cell transplantation and might serve as a diagnostic test for early differentiation of aGVHD from other transplanted related complications.

Regulation of acute graft-versus-host disease by microRNA-155.

TLDR
It is shown that miR-155 expression was up-regulated in T cells from mice developing aGVHD after alloHSCT, and this data indicate a role for microRNA-155 in the regulation of GVHD and point to mi R-155 as a novel target for therapeutic intervention in this disease.

Endothelial Microparticles Interact with and Support the Proliferation of T Cells

TLDR
Novel evidence is provided that EMP can enhance T cell activation and potentially ensuing Ag presentation, thereby pointing toward a novel role for MP in neuroimmunological complications of infectious diseases.

Evaluation of angiopoietins and cell-derived microparticles after stem cell transplantation.

  • S. NomuraK. Ishii K. Hayashi
  • Medicine, Biology
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2008

Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects.

TLDR
The Tc17 differentiation program during GVHD culminates in a highly plastic, hyperinflammatory, poorly cytolytic effector population, which is referred to as "inflammatory iTc17" (iTc17).

Microparticles: major transport vehicles for distinct microRNAs in circulation

TLDR
Findings describe an interesting mechanism for transferring gene-regulatory function from MP-releasing cells to target cells via MP circulating in blood, which represents transport vehicles for large numbers of specific miRNAs, which have been associated with cardiovascular diseases.

Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation.

  • M. PalomoM. Díaz-Ricart E. Carreras
  • Biology, Medicine
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
  • 2010
...